Bath & Body Works (NYSE:BBWI) Downgraded to “Hold” at Argus

Bath & Body Works (NYSE:BBWIGet Rating) was downgraded by equities researchers at Argus from a “buy” rating to a “hold” rating in a research report issued on Friday, MarketBeat reports.

Several other equities analysts have also commented on the company. Raymond James lowered their price objective on Bath & Body Works from $52.00 to $50.00 and set a “strong-buy” rating for the company in a research report on Friday, February 24th. Bank of America lifted their price target on Bath & Body Works from $48.00 to $50.00 in a research report on Thursday, November 17th. Credit Suisse Group lifted their price target on Bath & Body Works from $42.00 to $46.00 and gave the stock a “neutral” rating in a research report on Friday, February 24th. Jefferies Financial Group lifted their price target on Bath & Body Works from $45.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, January 31st. Finally, Barclays lifted their price target on Bath & Body Works from $39.00 to $43.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 22nd. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of “Moderate Buy” and a consensus target price of $49.52.

Bath & Body Works Trading Down 2.3 %

Shares of Bath & Body Works stock opened at $34.43 on Friday. The firm has a market capitalization of $7.86 billion, a P/E ratio of 9.98, a P/E/G ratio of 0.95 and a beta of 1.77. The business has a fifty day simple moving average of $42.85 and a two-hundred day simple moving average of $39.54. Bath & Body Works has a 12 month low of $25.75 and a 12 month high of $58.17.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. State of Alaska Department of Revenue grew its stake in shares of Bath & Body Works by 0.8% during the 4th quarter. State of Alaska Department of Revenue now owns 31,965 shares of the company’s stock valued at $1,347,000 after acquiring an additional 265 shares during the period. EverSource Wealth Advisors LLC grew its stake in shares of Bath & Body Works by 22.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,525 shares of the company’s stock valued at $64,000 after acquiring an additional 276 shares during the period. Captrust Financial Advisors grew its stake in shares of Bath & Body Works by 10.4% during the 1st quarter. Captrust Financial Advisors now owns 3,124 shares of the company’s stock valued at $149,000 after acquiring an additional 295 shares during the period. State of Michigan Retirement System grew its stake in shares of Bath & Body Works by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 62,071 shares of the company’s stock valued at $2,616,000 after acquiring an additional 300 shares during the period. Finally, Vanguard Personalized Indexing Management LLC grew its stake in shares of Bath & Body Works by 1.6% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 19,401 shares of the company’s stock valued at $818,000 after acquiring an additional 305 shares during the period. 96.34% of the stock is currently owned by institutional investors.

About Bath & Body Works

(Get Rating)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Further Reading

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.